Prevalence and risk factors of cytomegalovirus reactivation in critically Ill patients with COVID-19 pneumonia.
Tanapat TassaneeyasinSomnuek SungkanuparphSirawat SrichatrapimukAttawit CharoensriKanin ThammavaranucuptKulapong JayanamaSuppachok KirdlarpPublished in: PloS one (2024)
In critically ill COVID-19 patients, CMV reactivation is frequent and a high cumulative corticosteroids dose is a significant risk factor for CMV reactivation, which is associated with poor outcomes. Further prospective studies are warranted to determine optimal management.